Dosing of First Patients Shows Encouraging Early Results in the Investigational Use of Tc-99m-iPSMA for Prostate Cancer Screening Article by Doctor Omar Yehia, PI at the Misr Radiology Center Cairo, Egypt Doctor Omar Yehia is the Principal Investigator enrolled in the NOBLE Registry at the MISR Radiology Center in Cairo, Egypt. Early experience indicates that 99mTc-iPSMA SPECT can potentially identify lesions and important disease characteristics using technology which is already available in emerging markets. Read full article from Radiotheranostics Today >>